Interim Report Q3 2024
”After seven years, the transformation to growth is completed. We enter the next phase of Kinnevik with a strong financial position, and with a growth-focused portfolio consisting of a high-performing core and several exciting earlier stage companies with the potential to create significant outcomes. During the quarter, we continued to execute on our strategic priorities, investing more capital into our core company Spring Health and our newer venture Aira. Valuations in the core companies grew on the back of strong growth and improving margins, but a full write-down of our remaining VillageMD investment and the weaker dollar weighed on our Net Asset Value.”
Georgi Ganev, CEO of Kinnevik
Third Quarter 2024 Highlights
Kinnevik in numbers
37.4bn
Sek, Net asset value
132
Nav per share
(4.8)%
Change in nav Q/Q
(14)%
Change in nav Y/Y
(8)%
1 year TSR
(3)%
5 year TSR
Conference Call 10am CET
You are welcome to listen to the conference call presenting the 2024 third quarter results.
(listen only)
Those who wish to participate in the teleconference are welcome to register via the below link. Participants will receive dial-in numbers and confirmation code upon registration. Please make sure to register and dial in a few minutes before the teleconference begins.
(for participants)